Created at	Source	Raw Value	Validated value
March 7, 2021, 12:31 a.m.	usa	Incidents of treatment-adverse events as assessed by FDA Toxicity grading scale.;Number of participants with humoral immune response at Study Day 43 (+/- 2).;Number of participants with local and systemic reactions	Incidents of treatment-adverse events as assessed by FDA Toxicity grading scale.;Number of participants with humoral immune response at Study Day 43 (+/- 2).;Number of participants with local and systemic reactions